Clinical Trial Update: Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45) [Phase 2]

View source ↗

Summary

This clinical trial update reports results from an observational study assessing cognitive outcomes in individuals who previously underwent PET amyloid imaging …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Florbetapir F-18 (AV-45) (Florbetapir F-18)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | Phase 2 | Status: COMPLETED | Results posted: 2013-03-28